Table 1 Comparison of Clinical characteristics and outcomes between AP patients with versus without high serum Ferritin levels
Variable | Overall | Normal SF | High SF | P value |
|---|---|---|---|---|
N = 200 | N = 108 | N = 92 | ||
Age (mean ± sd), yrs | 57.1 ± 15.7 | 56.3 ± 15.3 | 57.8 ± 16.3 | 0.503 |
Male sex, N (%) | 110 (55%) | 44 (40.7%) | 66 (71.7%) | < 0.001 |
Smoking, N (%) | 43 (21.5%) | 20 (18.5%) | 23 (25%) | 0.303 |
Drinking, N (%) | 29 (14.5%) | 13 (12.0%) | 16 (17.4%) | 0.301 |
Weight (mean ± sd) | 70.6 ± 12.3 | 67.6 ± 12.0 | 73.4 ± 12.1 | 0.021 |
Underlying disease, N (%) | ||||
Diabetes | 19 (9.5%) | 8 (7.4%) | 11 (12.0%) | 0.285 |
Hypertension | 30 (15%) | 14 (13.0%) | 16 (17.4%) | 0.385 |
Coronary heart disease | 13 (6.5%) | 6 (5.6%) | 7 (7.6%) | 0.560 |
Fatty liver | 26 (13%) | 15 (13.9%) | 11 (12.0%) | 0.687 |
Etiology, N (%) | Â | Â | Â | 0.094 |
Biliary | 101 (50.5%) | 51 (47.2%) | 50 (54.3%) | Â |
Alcohol | 14 (7%) | 8 (7.4%) | 6 (6.5%) | Â |
Hypertriglyceridemia | 41 (20.5%) | 19 (17.6%) | 22 (23.9%) | Â |
Others | 44 (22%) | 30 (27.8%) | 14 (15.2%) | Â |
Severity, N (%) |  |  |  | < 0.001 |
MAP | 149 (74.5%) | 94 (63.1%) | 55 (36.9%) | Â |
MSAP | 38 (19%) | 11 (28.9%) | 27 (71.1%) | Â |
SAP | 13 (6.5%) | 3 (23.1%) | 10 (76.9%) | Â |
SIRS, N (%) | 69 (34.5%) | 28 (25.9%) | 41 (44.6%) | 0.006 |
Ranson score | 1.5 ± 1.0 | 1.0 ± 0.9 | 2.0 ± 1.0 | < 0.001 |
CTSI score | 2.1 ± 1.2 | 1.7 ± 0.9 | 2.6 ± 1.4 | < 0.001 |
BISAP score | 0.9 ± 0.7 | 0.5 ± 0.6 | 1.3 ± 0.7 | < 0.001 |
Local complications, N (%) | 28 (14%) | 8 (7.4%) | 20 (21.7%) | 0.005 |
Systemic complications, N (%) | 10 (5%) | 3 (2.8%) | 7 (7.6%) | 0.133 |